Hua's goal is to be the leading, innovative drug development and commercialization company in China, targeting novel therapies to address the unmet medical needs of patients world-wide. The company leverages the efficient and high-quality drug discovery capabilities available in China, while partnering or licensing the best drug assets from Asia, the US and EU. Through these efforts, Hua intends to be the driving force behind China's evolution into a global innovation center for drug development.
4.24 2013
2012年度浦东“百人计划”揭晓 12名高层次人才入选
1.9 2013
美中医药开发协会中国主席陈力:深刻变革中的生物医药产业
11.28 2012
China’s Green Channel Significantly Shortened Filing Time For Start-up Hua Medicine
11.23 2012
Hua Medicine Advances Diabetes Treatment toward Trial
6.19 2012
Biotech is a fast growing sector in China – both for manufacturing and R&D.
5.23 2012
华医药CEO陈力博士:开创新的医药企业运营模式
- part1
- part2
- part3
3.2 2012
华医药获得罗氏葡萄糖激酶激动剂独家市场运作
2.20 2012
原创新药刺激全球联动
12.30 2011
华医药向中国市场引进罗氏治疗糖尿病创新药
12.26 2011
华医药获罗氏糖尿病创新药开发权,全球上市将首选中国